Hims & Hers Expands Weight Loss Portfolio with Novo Nordisk Partnership
The telehealth company Hims & Hers has taken a decisive step into the competitive GLP-1 market. It has now opened ...
The telehealth company Hims & Hers has taken a decisive step into the competitive GLP-1 market. It has now opened ...
A significant strategic pivot by telehealth provider Hims & Hers has prompted a swift reassessment from Wall Street. The company ...
In a strategic pivot that reshapes its market position, telehealth provider Hims & Hers Health has entered a major collaboration ...
A major legal overhang for the telehealth company Hims & Hers has been decisively removed, sending its shares skyrocketing. The ...
After a punishing multi-month decline, shares of telehealth provider Hims & Hers are showing tentative signs of life. This nascent ...
The telehealth company Hims & Hers finds itself navigating a perfect storm of regulatory scrutiny and legal action, leading to ...
The recent foray by telehealth company Hims & Hers into the lucrative weight-loss medication sector has hit an early regulatory ...
The telemedicine provider Hims & Hers is navigating a complex competitive landscape. Amid recent pressure on its share price, the ...
The telehealth provider Hims & Hers officially launched operations in Canada on December 4, 2025. This strategic move was executed ...
The investment case for Hims & Hers Health is currently defined by a stark tug-of-war. On one side, a bold ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com